When may response-time curves be more useful than concentration-time curves?

When may response-time curves be more useful than concentration-time curves?

• A. When concentrations correlate with response
• B. When concentrations don't correlate with response
• C. When there is a direct dose-response relationship
• D. When patient variability is minimal

Answer: (B)

When the drug’s effect does not closely follow the plasma concentration over time, using the time course of the response can be more informative than the concentration-time profile. This happens when there is a lag between changes in concentration and the observed effect (a hysteresis pattern), often due to distribution to the effect site, receptor kinetics, or active metabolites that reach the site of action after plasma levels have already changed. In such cases, a response-time curve directly tracks how the effect rises and falls, showing onset, time to peak effect, and duration more accurately than a concentration-time curve. If concentrations do correlate with response, the concentration-time curve already provides a good sense of the effect over time, so switching to a response-time perspective offers less added value. Similarly, a direct dose–response relationship implies a straightforward link between dose and effect, but it doesn’t guarantee that time aspects are unimportant; however, the question asks when response-time curves may be more useful, and the strongest situation is when plasma levels don’t predict the effect well. Minimal patient variability would also reduce the need for separate response-time analysis, since predictable pharmacodynamics can often be inferred from concentration data alone.

When the drug’s effect does not closely follow the plasma concentration over time, using the time course of the response can be more informative than the concentration-time profile. This happens when there is a lag between changes in concentration and the observed effect (a hysteresis pattern), often due to distribution to the effect site, receptor kinetics, or active metabolites that reach the site of action after plasma levels have already changed. In such cases, a response-time curve directly tracks how the effect rises and falls, showing onset, time to peak effect, and duration more accurately than a concentration-time curve.

If concentrations do correlate with response, the concentration-time curve already provides a good sense of the effect over time, so switching to a response-time perspective offers less added value. Similarly, a direct dose–response relationship implies a straightforward link between dose and effect, but it doesn’t guarantee that time aspects are unimportant; however, the question asks when response-time curves may be more useful, and the strongest situation is when plasma levels don’t predict the effect well. Minimal patient variability would also reduce the need for separate response-time analysis, since predictable pharmacodynamics can often be inferred from concentration data alone.